4.3 Review

Role of Biomarkers in the Diagnosis and Management of Cardio-Renal Syndromes

期刊

SEMINARS IN NEPHROLOGY
卷 32, 期 1, 页码 79-92

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.semnephrol.2011.11.011

关键词

Biomarkers; brain natriuretic peptide; cardio-renal syndrome; cystatin C; heart failure; fatty acid binding proteins; interleukin-18 (IL-18); kidney injury molecule-1 (KIM-1); myeloperixidase; N-acetyl-beta-(D)-glucosaminidase (NAG); neutrophil gelatinase associated lipocalin (NGAL); troponin

资金

  1. Abbott Diagnostics

向作者/读者索取更多资源

The complex interaction between heart and kidney disease has been increasingly recognized over the recent years. Pathologies within these two organs frequently coexist and, due to organ cross-talk, dysfunction in one often leads to problems in the other. The classification of the various forms of cardio-renal syndrome has made these interactions clearer. To aid in the diagnosis, management and prognosis of these conditions, many novel cardiac and renal biomarkers have emerged to supplement traditional markers which have limited specificity and sensitivity. In this review we will summarize the literature on novel renal behind these and other biomarkers and discuss their potential relevance to the clinical scenarios of cardio-renal syndrome. Semin Nephrol 32:79-92 (C) 2012 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据